mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.8 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.8 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.0098 |
0.8 |